Indications

• Thrombocythemia
• Myeloproliferative Disorders

Adverse Effects

• Pneumonitis (see Pneumonia)
• Interstitial Lung Disease (see Interstitial Lung Disease-Etiology)

References

• Severe Hypersensitivity Pneumonitis Associated with Anagrelide. Ann Pharmacother September 2003 vol. 37 no. 9 1228-1231
• Anagrelide-Induced Pneumonitis: Case Report and Review of the Literature. CJHP – Vol. 61, No. 3 – May–June 2008